Antipsychotics are not addictive in the way most people mean when they ask this question. They don’t produce a high, they don’t trigger drug-seeking behavior, and they aren’t classified as substances of abuse in the DSM-5. But stopping them abruptly can cause real physical withdrawal symptoms, and one specific antipsychotic has a notable pattern of misuse. The distinction between addiction and physical dependence is central to understanding what these medications actually do in your body.
Why Antipsychotics Don’t Work Like Addictive Drugs
Addictive substances, like opioids, stimulants, and alcohol, hijack the brain’s reward system. They flood dopamine into the pathways responsible for pleasure and motivation, creating a cycle of craving and compulsive use. Antipsychotics do the opposite. They block dopamine receptors rather than stimulating them, which is why they reduce psychotic symptoms but don’t produce euphoria. There’s no “rush,” no reinforcing high that drives you to seek more.
The DSM-5 defines substance use disorders using 11 criteria, including things like consuming a substance in larger amounts than intended, craving it, continuing to use it despite social harm, and needing increasing doses to get the same effect. Antipsychotics don’t fit this pattern. People prescribed antipsychotics are far more likely to want to stop taking them than to compulsively seek more. The medications are often experienced as dulling or sedating rather than rewarding.
Physical Dependence Is Real
Even though antipsychotics aren’t addictive, your brain does adapt to their presence. When you take an antipsychotic for months or years, your brain compensates for the blocked dopamine receptors by producing more of them, a process called receptor upregulation. This is your nervous system trying to restore balance. The result is that when the medication is removed, especially abruptly, your brain is temporarily flooded with more dopamine activity than it can handle. This mismatch causes withdrawal symptoms.
A systematic review in Frontiers in Psychiatry found that abrupt antipsychotic discontinuation produces a consistent set of physical and psychological symptoms: nausea and vomiting, abdominal pain, diarrhea, headache, rapid heartbeat, dizziness, excessive sweating, muscle pain, restlessness, anxiety, tension, and insomnia. These symptoms typically begin within four weeks of stopping the medication and last one to four weeks, though involuntary movements can persist for months.
This is physical dependence, not addiction. Your body has adjusted to the drug’s presence and reacts when it’s removed. The same thing happens with blood pressure medications, certain antidepressants, and steroids. None of those are considered addictive either.
Rebound Psychosis and Dopamine Supersensitivity
One of the more concerning effects of stopping antipsychotics is the possibility of rebound psychosis. Long-term use, especially at high doses, can cause the brain to become hypersensitive to dopamine by increasing the density of dopamine receptors. When the medication is removed, this supersensitivity can trigger a psychotic episode that looks like a relapse of the original condition but is actually a withdrawal effect.
This creates a frustrating cycle. A person stops their medication, experiences a psychotic episode within days or weeks, and both they and their provider assume the illness has returned. In reality, the episode may be caused by the brain’s exaggerated response to the sudden absence of the drug. Distinguishing withdrawal from true relapse is tricky, but timing is a key clue: withdrawal symptoms tend to appear within days of stopping or reducing the dose and often improve quickly if the medication is restarted. A genuine relapse typically develops more gradually.
Quetiapine Is a Notable Exception
One antipsychotic stands out for its misuse potential: quetiapine (sold as Seroquel). A retrospective analysis of US poison control data from 2003 to 2013 found that quetiapine accounted for 60.6% of all antipsychotic-related misuse cases. Among people who misuse substances, surveys have identified quetiapine as the most commonly misused antipsychotic, reported by 90% of respondents, compared to 28% for the next most common.
A US population survey estimated that about 3.9% of quetiapine users had taken it outside of medical guidance at some point, compared to 2.7% for olanzapine. The reasons varied. About 31% of those who misused quetiapine did so to enhance the effects of another drug. Roughly 29% used it to cope with withdrawal from another substance. Around 40% took it because their prescribed medications weren’t relieving their symptoms, and about 32% used it because they could no longer obtain a medication they previously had access to.
Quetiapine’s misuse profile likely stems from its strong sedating effects at low doses. People sometimes use it as a sleep aid, an anxiety reducer, or to come down from stimulants. This is a pattern of misuse, but it’s different from the compulsive, escalating use seen with classically addictive drugs. The sedation is the draw, not euphoria.
Why Tapering Matters
Because the brain adapts to antipsychotics, stopping safely requires a slow, gradual reduction rather than quitting cold turkey. Research published in Schizophrenia Bulletin suggests a specific approach: reducing by about one quarter of the most recent dose every three to six months, with each successive reduction being smaller than the last. This “hyperbolic” tapering method accounts for the fact that dopamine receptor blockade doesn’t decrease in a straight line as the dose drops. Small dose reductions at lower doses have a disproportionately large effect on brain chemistry.
Some people prefer an even more cautious pace, reducing by 10% or less of their most recent dose each month. The process can take months or even years depending on how long someone has been on the medication and how their body responds. After each reduction, a waiting period of three to six months allows enough time to see whether withdrawal symptoms or signs of relapse emerge before making the next cut.
This gradual approach is important precisely because of receptor upregulation. Each dose reduction gives the brain time to recalibrate, slowly reducing the number of extra dopamine receptors it built up during treatment. Rushing this process increases the risk of both uncomfortable withdrawal symptoms and rebound psychosis.
Dependence Without Addiction
The confusion between dependence and addiction is understandable. Both involve the body adapting to a substance, and both can produce withdrawal symptoms. But addiction requires a psychological component: craving, compulsive use, loss of control, and continued use despite harm. Antipsychotics don’t produce these patterns in the vast majority of people who take them. If anything, the most common problem is the opposite: people stopping their medication too soon because the side effects feel worse than the benefits.
Your body will adjust to antipsychotics over time, and stopping abruptly can make you feel genuinely unwell. That’s a reason to work with a prescriber on a careful tapering plan, not a sign that the medication has you hooked. The distinction matters because fear of addiction keeps some people from starting or continuing medications that meaningfully improve their quality of life.